| Veröffentlichte Version Download ( PDF | 94kB) Nur für Mitarbeiter des Archivs |
Massive haemolysis after intramuscular diclofenac in a patient who apparently tolerated oral medication
Ahrens, Norbert
, Schewior, L., Garbe, E., Kiesewetter, H. und Salama, A.
(2004)
Massive haemolysis after intramuscular diclofenac in a patient who apparently tolerated oral medication.
Vox sanguinis 86 (1), S. 71-74.
Veröffentlichungsdatum dieses Volltextes: 22 Dez 2021 10:00
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.51263
Zusammenfassung
Background and Objectives Administration of diclofenac may lead to immune haemolytic anaemia (IHA) owing to the presence of drug-dependent antibodies and/or autoantibodies. A relationship with oral or intramuscular drug administration is unknown. Here, we describe a patient who apparently tolerated oral diclofenac but developed severe IHA following intramuscular injection of the ...
Background and Objectives
Administration of diclofenac may lead to immune haemolytic anaemia (IHA) owing to the presence of drug-dependent antibodies and/or autoantibodies. A relationship with oral or intramuscular drug administration is unknown. Here, we describe a patient who apparently tolerated oral diclofenac but developed severe IHA following intramuscular injection of the drug.
Patients and Methods
A 66-year-old-female was admitted to hospital because of jaundice and nausea, which were initially presumed to be manifestations of a postcholecystectomy syndrome. The patient soon developed haemolysis and renal failure. Although the symptoms and signs were suggestive of autoimmune haemolytic anaemia (AIHA), the patient had diclofenac-induced IHA.
Results
Serological testing, including detection of drug-dependent antibodies, was performed using standard techniques. The patient's serum was found to contain a highly reactive diclofenac-dependent red cell antibody of the immune complex type (titre 256 000). She recovered after 7 weeks of treatment with prednisolone, blood transfusions, haemodialysis and plasma exchange.
Conclusions
Diclofenac-induced IHA should always be considered when a patient on diclofenac develops haemolysis.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Vox sanguinis | ||||
| Verlag: | Wiley | ||||
|---|---|---|---|---|---|
| Band: | 86 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 1 | ||||
| Seitenbereich: | S. 71-74 | ||||
| Datum | 30 Januar 2004 | ||||
| Institutionen | Medizin > Lehrstuhl für Klinische Chemie und Laboratoriumsmedizin | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | diclofenac, drug-dependent antibodies, drug-induced haemolysis, immunehaemolytic anaemia | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Zum Teil | ||||
| Dokumenten-ID | 51263 |
Downloadstatistik
Downloadstatistik